Abstract:NADPH oxidase (NOX) has been shown to play a critical role in the development of cardiac hypertrophy induced by angiotensin II and α1-adrenergic receptor (AR) stimulation. Overexpression of a V204A DN mutant of NOX cytosolic subunit p67phox (DN-p67) was reported to prevent NOX-mediated superoxide generation in vitro. Recently, we found that overexpression of the DN-p67 mutant attenuated α1-AR-induced hypertrophy in cultured cardiac myocytes. In order to further investigate the role of NOX/67phox in cardiac hypertrophy in vivo, we generated a Tg mouse model with cardiac-specific overexpression of the above V204A DN-p67 coding region. For the convenience of transgene screening, an enhanced green fluorescent protein (EGFP) gene was linked downstream to the DN-p67 transgene. The independent translation of the EGFP was initiated by a leading viral sequence for internal ribosome entry site (IRES) that was linked to the 3'end of DN-p67. The DN-p67-IRES-EGFP transgene was next linked to the 3'end of a cardiac-specific a-MHC promoter generating a 9.1-Kb transgene that contains the α-MHC promoter, the DN-p67 coding region, the IRES-EGFP sequence, and a polyadenylation signal sequence. This new transgene was then injected into fertilized C57BL/6J zygotes that were transplanted into pseudopregnant mice. The obtained offspring mice were screened for transgene integration by PCR analysis and Southern blotting of tail DNA. Two pairs of PCR primers were used in screening to detect either a 640-bp EGFP coding sequence or a 277-bp region span the junction between the α-MHC promoter and the DN-p67 coding sequence. Three Tg-positive founder mice (2 male and 1 female) were obtained. Currently, at age of 18 weeks, the 3 founder mice are all viable and healthy with normal phenotypes. At age of 10 weeks, each of the 3 founders was bred to wild type (WT) C57BL/6J mice independently, and had produced 6 DN-p67 Tg offspring at present. These heterozygous Tg littermates will be used to independently breed for homozygous DN-p67 Tg lines derived from each of the 3 Tg founders. In summary, we have generated a Tg mouse model with cardiac-specific overexpression of a DN mutant of p67phox, which would be a useful in vivo model for studying cardiac diseases involving NOX/p67phox.

Generation of a tamoxifen inducible Tnnt2MerCreMer knock‐in mouse model for cardiac studies

A Murine Myh6MerCreMer Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction.

Inducible Cardiomyocyte-Specific Gene Disruption Directed by the Rat Tnnt2 Promoter in the Mouse

Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein

Generating Endogenous Myh11-driven Cre Mice for Sex-Independent Gene Deletion in Smooth Muscle Cells

Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron

Generation of a Transgenic Mouse Model with Chondrocyte-Specific and Tamoxifen-Inducible Expression of Cre Recombinase.

Generation of Tamoxifen-Inducible Tfap2b-CreERT2 Mice Using CRISPR-Cas9.

Generation of a novel constitutive smooth muscle cell-specific Myh11-driven Cre mouse model

[Generation of Tnnt2a Knock-out Zebrafish Via CRISPR/Cas9 and Phenotypic Analysis].

Combinatorial Genetic Replenishments in Myocardial and Outflow Tract Tissues Restore Heart Function in Tnnt2 Mutant Zebrafish.

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts

Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo.

Generation and Characterization of Transgenic Mice Expressing Tamoxifen-Inducible Cre-Fusion Protein Specifically in Mouse Liver.

Generation of a Transgenic (tg) Mouse Model with Cardiac Specific Overexpression of a Dominant Negative (DN) Mutant of P67phox

4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice

Inducible and reversible regulation of endogenous gene in mouse.

A tamoxifen-inducible Cre knock-in mouse for lens-specific gene manipulation

Limitations of Tamoxifen Application for In Vivo Genome Editing Using Cre/ERT2 System

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene